Frontiers in Cardiovascular Medicine

Confident young woman gesturing while teaching students in class

Submit your research

Start your submission and get more impact for your research by publishing with us.

Active senior woman concentrating while working on laptop

Author guidelines

Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript.

Front view portrait of African American man wearing lab coat and raising hand asking question while sitting in audience and listening to lecture on medicine

Editor guidelines

Reviewing a manuscript? See our editorial guidelines for everything you need to know about Frontiers’ peer review process.

Smiling colleagues doing research over laptop computer on desk in office

Peer review

Our efficient and rigorous peer review means you’ll get a decision on your manuscript in just 77 days.

Interior of a library with desks and bookshelves

Publishing fees

Article processing charges (APCs) apply to articles that are accepted for publication by our external editors, following rigorous peer review.

Journal notices

cultured human cells stained with fluorescent dyes (cardiac myofibroblasts stained for calponin in green, N-cadherin in red, and in blue for DNA)

Research Topic of the month

Led by Prof. Ryuichi Morishita and Fumihiro Sanada (Osaka University): explore senescence-driven CVD, SASP, age-specific biomarkers, senolytics/senomorphics, and AI insights. Submit your research

Submission closing: evidence of atherogenic lipoproteins

Led by Drs. Chen & Akyol (Texas), Akhmedov (Zurich), and Sanchez Quesada (Barcelona), the research topic is dedicated to advancing our grasp of atherogenic lipoproteins. Last call for papers - collection is closing soon.

eBook of the month

Discover the eBook Advances in Diabetes and Hypertension Research, edited by Dr. Argano and Dr. Scaglione. It explores interactions between diabetes and hypertension and identifies novel biomarkers of cardiometabolic and cerebrovascular risk.

Targeting the hallmarks of aging

Discover how genomic instability, senescence, mitochondrial dysfunction, and other hallmarks drive aging—and how senolytics, NAD+ boosters, caloric restriction mimetics, and regenerative therapies may slow or even reverse biological aging.

Cardio-Oncology

Submit your research

Author guidelines

Editor guidelines

Peer review

Publishing fees

Journal notices

Research Topic of the month

Submission closing: evidence of atherogenic lipoproteins

eBook of the month

Targeting the hallmarks of aging

Editors

jun-ichi abe

joerg herrmann

abdelrahman i abushouk

louisa antoni

Articles

NO/NOS system dysregulation as a key molecular mechanism in chemotherapy-induced cardiotoxicity: a review

Investigation of Sheng Mai Yin in the treatment of anthracycline-induced frequent premature ventricular contractions in cancer patients: study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial

Soluble suppression of tumorigenicity-2 changes during cardiotoxic cancer treatment: a systematic review and meta-analysis

Case Report: Diagnostic challenges and therapeutic approaches in cardiac intimal sarcoma: a rare clinical case study

Research Topics

The Core Curriculum of Cardio-Oncology at University of Texas MD Anderson and Mayo Clinic: Educational Material Prepared for Practioners and Trainees

Novel Insights in Cardiovascular toxicity induced by New Anticancer Treatments

Use of Radiation in Cardiac Tissue: Mechanisms, Therapeutic Applications, Protocols, and Clinical Outcomes

Cardio-Oncology in the Era of Precision Medicine: Risk Stratification, Surveillance, and Cardioprotection Across the Cancer Continuum